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Abstract
This report describes the case of an 88-year-old non-diabetic female who presented to the emergency
department  severely hypothermic following a presumed hypoglycaemic collapse due to self-neglect.
Subsequent rewarming and resuscitation demonstrated a number of the significant  consequences of
severe  hypothermia,  including  apparent  secondary  impairment  of  glycaemic  autoregulation.  The
phenomenon of reversible inhibition  of insulin  secretion due to severe hypothermia  has previously
been  documented  in  the  field  of  cardiac  surgery.  The  hyperglycaemia  was  not  treated  with  any
antihyperglycaemic agent, and her recovery was uneventful. Subsequent blood sugar level monitoring
was  normal.  If  administering  insulin  to  the  hypothermic  patient,  intensive  monitoring  of  blood
glucose is essential due to the increase in endogenous insulin secretion on rewarming.
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1. Introduction
Accidental  hypothermia  is a potentially life-threatening  condition of particular  concern  during  the
winter months, although it may occur in any season. Hypothermia may be classified according to core
body temperature as mild (35 to 32C), moderate (32 to 30C) or severe (less than  30C) [1], and
predisposing  factors  may  include  impairment  of  thermoregulation,  a  cold  external  environment,
neglect  (including  self-neglect),  hypothyroidism,  and  hypoglycaemia  [1-3].Systemic  effects  of
hypothermia may include cardiac arrhythmias, loss of normal glycaemic control, and depressed level
of consciousness [1,4-6].  The Advanced Life Support  Course Provider  Manual  [1]  offers guidance
regarding  many  aspects  of  rewarming  the  hypothermic  patient  but  does  not  specifically  address
glycaemic control.  The case described here illustrates that  significant  derangements of blood sugar
level may be encountered in severe hypothermia, even in the non-diabetic patient.
2. Case Report
An 88-year-old lady seemed confused and dysarthric when telephoned by her daughter. The daughter
entered her home with police assistance, and found her lying on the floor partially clad and unable to
communicate. Examination of the house showed that she had not been to bed the night before. She
was last seen by her daughter twenty hours previously, at which time she had appeared fit and well.
Her  only  pre-existing  medical  conditions  were  high  blood  pressure  and  treated  hypothyroidism,
though her appetite had been poor for some time. At the scene the paramedics found her blood sugar
level (BSL) to be 1.2mmol l-1 and administered intramuscular glucagon. On arrival in hospital it had
risen to only 1.9mmol l-1. Her Glasgow Coma Scale (GCS) score was noted to be 11 (Eyes 4 Verbal 2
Motor 5) and her temperature by tympanic thermometer was 27.8C. She was maintaining her own
airway, breathing  spontaneously,  and  had  an  irregular  femoral  pulse of 60bpm.  A brachial  blood
pressure reading could not be obtained. Secondary survey revealed only a minor skin tear to the left
elbow. Pupils were noted to be unreactive but the daughter related a history of cataract surgery.
Active rewarming was commenced. As the time of initial onset of hypothermia was unknown it was
decided to rewarm at a rate of one degree per hour, giving a total rewarming time of ten hours. This
was achieved by means of a warm air blanket and warmed intravenous fluids. She was catheterised to
allow monitoring of urine output and offer the option of warm bladder lavage if her core temperature
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failed to rise. 50ml of 50% dextrose was administered intravenously for hypoglycaemia, resulting in a
rapid increase in BSL to 20.4mmol l-1. BSL then remained persistently elevated, falling gradually to
10.9mmol l-1 at ten hours and 7.7mmol l-1 after fourteen hours (see Figure 1).
Arterial  blood gases showed her  to have severe metabolic acidosis  due to lactic acidosis,  with  an
uncorrected pH of 7.05, a pCO2 of 2.4kPa, and a blood lactate of 15.0mmol/L (see Table 1). This is
attributable to poor tissue perfusion resulting from her hypothermia.
Her blood pressure became measurable after half an hour at 94/26 mmHg and after one hour, with a
core temperature by tympanic probe of 28.7C, her GCS had risen to 14 (Eyes 4 Verbal 4 Motor 6).
She remained dysarthric and confused. Neurological examination at this time was otherwise normal.
Cardiac  monitoring  showed initial  slow atrial  fibrillation  (AF) interrupted by spells  of ventricular
fibrillation,  however  the  latter  were  consistently  of  less  than  a  second  in  duration  and  resolved
spontaneously. Towards the end of the first hour these spells ceased and she remained in slow AF.
She was then transferred to HDU for continued rewarming,  and received a one-off 200mg bolus of
intravenous hydrocortisone on suspicion of a possible autoimmune process targeting thyroid, pancreas
and adrenal glands.
The  following  day  she  was  both  normothermic  and  consistently  normoglycaemic,  with  a  blood
pressure  of  147/66  mmHg,  a  pulse  of  78bpm  in  sinus  rhythm,  and  both  the  confusion  and  the
dysarthria  had  resolved.  She  was  therefore  transferred  to  a  medical  ward.  On  examination  she
appeared neurologically intact.  The remainder  of her  stay was uneventful  and  she was discharged
home with a care package four weeks later.  Outpatient  clinic follow-up at 1 month post discharge
revealed significant and symptomatic postural hypotension (BP 120/60 lying, 80/40 standing), which
was successfully treated by adjusting her blood pressure medications. She continued fit and well at 4
months post discharge and no further hospital follow-up has been planned.
3. Discussion
It  is  hypothesised  that  this  patient  became hypoglycaemic  as  a  result  of poor  appetite  leading  to
prolonged  self-neglect.  This  led  to  a  depressed  level  of  consciousness,  and  a  combination  of
hypoglycaemia, exposure and possible hypothyroidism caused her to become hypothermic. Failure to
respond to glucagon may have been caused by decreased muscular perfusion due to immobility and
hypothermia,  or  it  may  have  reflected  low hepatic  stores  of  glycogen  resulting  from  both  poor
nutrition and overnight fast, or an altered metabolism secondary to hypothermia [4]. Her prolonged
hyperglycaemia  following  a  bolus  of 50% dextrose  is  unlikely to  be diabetic  in  origin  given  the
negative  history  and  subsequent  normal  glycaemic  autoregulation.  Steroids  can  affect  glycaemic
homeostasis but after administration of 50% dextrose there was an interval of over an hour before the
patient  received hydrocortisone,  during  which  normal  glycaemic autoregulation  was conspicuously
absent. It may be attributable in part to the slow absorption of glucagon from the injection site but at
this  stage  little  rewarming  had  actually  taken  place  and  we may  assume  that  muscle  perfusion
remained  poor.  The  most  likely  cause  of  the  hyperglycaemia  is  the  development  of  reversible
suppression of insulin  secretion as a result  of hypothermia,  as has previously been documented in
patients  undergoing  hypothermic  cardiac  surgery  [4-6].  If  intravenous  insulin  is  administered,
pancreatic secretion of insulin on rewarming may be disproportionate to physiological requirements,
carrying the risk of rebound hypoglycaemia [6-7]. Peripheral  insulin resistance has also been noted
during hypothermic cardiac surgery [4] but is attributable to anaesthesia and surgical stress. Whether
hypothermia  also causes peripheral  insulin  resistance,  necessitating  increased  doses of exogenous
insulin, is unclear. The key to good glucose control in the hypothermic patient is therefore intensive
monitoring  of blood glucose  level,  together  with  careful  administration  of an  exogenous  insulin
infusion if indicated.  Subsequent to this patient  receiving hydrocortisone, disturbance of glycaemic
autoregulation due to steroids may also have become significant. Once again,  intensive monitoring,
together with careful and appropriate use of exogenous insulin will provide optimal glucose control. 
Many of the physiological disturbances arising from hypothermia resolve spontaneously as the core
temperature rises.  In this patient,  cardiac arrhythmia,  loss of glycaemic regulatory function,  severe
metabolic acidosis and neurological dysfunction all resolved through simple supportive measures and
an appropriate programme of careful rewarming.
The patient  did  not  receive exogenous insulin  but  a  review of the  literature  suggests this  may be
beneficial.  Good glycaemic control  in  surgical  patients  is  associated  with  a  reduced risk  of post-
operative infection [8] and a significant  reduction in  morbidity and mortality in  the Intensive Care
Unit [9]. In particular, significant reductions were demonstrated in rates of septicaemia and mortality
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due to septic foci, and  also of acute renal  failure and  critical-illness  polyneuropathy. Whether  the
benefit also extends to medical patients remains unproven but as intravenous insulin therapy is well
tolerated, tight glycaemic control offers considerable potential benefits at relatively low risk.
4. Conclusion
Severe  hypothermia  may  cause  a  reversible  failure  of  insulin  secretion  and  peripheral  insulin
resistance. In the hyperglycaemic hypothermic patient who is not a known diabetic, while tight blood
glucose control may potentially confer a significant mortality benefit, the care team should be aware
that the patient may exhibit rebound hypoglycaemia when secretion of endogenous insulin resumes,
and  intensive  monitoring  of  blood  glucose  levels  is  therefore  necessary.  As  the  secretion  of
endogenous insulin may at first be excessive, intensive monitoring should continue even after return
of spontaneous normoglycaemia.
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Table 1
Arterial blood gas analysis report on admission
Parameter Value
Temperature 27.8 C (Tympanic)
pH (measured) 7.05
pH (temperature corrected) 7.16
pO2 (measured) 32.8 kPa
pO2 (temperature corrected) 27.5 kPa
pCO2 (measured) 2.4 kPa
pCO2 (temperature corrected) 1.6 kPa
Na+ 128 mmol/L
K+ 4.1 mmol/L
Ca++ 1.19 mmol/L
Corrected Ca++ (pH 7.4) 1.03 mmol/L
Glucose 20.4 mmol/L
Lactate 15.0 mmol/L
HCO3- 5.0 mmol/L
Plasma CO2 5.6 mmol/L
Base Excess (extracellular fluid) -25.5 mmol/L
Base Excess (blood) -24.3 mmol/L
Hb 12.4 g/dL
Haematocrit 40.00%
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